West Africans have a high risk of kidney disease – new study confirms genetic cause
Our study thus confirmed what was found in people of African descent in the US: the genetic origin underpinning the excess ...
Q4 2024 Mineralys Therapeutics Inc Earnings Call
Jon Congleton; Chief Executive Officer, Director; Mineralys Therapeutics Inc. David Rodman; Chief Medical Officer ...
Americans eat too much sodium. 8 salt substitutes to help you cut back — and protect your heart health.
Cardiac and pulmonary wellness dietitian Sheri Gaw tells Yahoo LIfe that “salt alternatives are especially helpful for people ...
Blood test can predict preterm preeclampsia with 80% accuracy
A new blood test has an 80% accuracy in predicting preterm preeclampsia, according to a study published today, Feb. 12, in ...
Genetic map identifies 1,000 potential kidney disease treatment targets
More than 1,000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study, ...
GlobalData on MSN2d
Maze Therapeutics doses first subject in Phase II AKD treatment trial
Maze Therapeutics has dosed the first subject in the Phase II HORIZON study to evaluate its oral apolipoprotein L1 (APOL1) ...
UUHC Health Feed2d
How to Prevent High Blood Pressure
High blood pressure, or hypertension, is the leading cause of global mortality and cardiovascular disease. While there is no ...
Science Daily8h
New blood test accurately predicts preeclampsia
A new blood test has an 80% accuracy in predicting preterm preeclampsia, according to a new study. The condition, which results in over 70,000 maternal deaths and 500,000 fetal deaths each year ...
Mineralys outlines pivotal trial timelines for lorundrostat in hypertension
CEO Jon Congleton highlighted the company's focus on advancing its pivotal trials for lorundrostat, targeting dysregulated aldosterone in patients with uncontrolled and resistant hypertension. He ...